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Abstract
Background: Both hypoxia and hyperoxia, deregulating the oxidative balance, may play a role in the pathology of
neurodegenerative disorders underlain by cerebral ischemia. In the present study, quantitative proton magnetic
resonance spectroscopy was used to evaluate regional metabolic alterations, following a 24-hour hypoxic or
hyperoxic exposure on the background of ischemic brain insult, in two contrasting age-groups of rats: young - 3
months old and aged - 24 months old.
Methods: Cerebral ischemia was induced by ligation of the right common carotid artery. Concentrations of eight
metabolites (alanine, choline-containing compounds, total creatine, g-aminobutyric acid, glutamate, lactate, myo-
inositol and N-acetylaspartate) were quantified from extracts in three different brain regions (fronto-parietal and
occipital cortices and the hippocampus) from both hemispheres.
Results: In the control normoxic condition, there were significant increases in lactate and myo-inositol
concentrations in the hippocampus of the aged rats, compared with the respective values in the young ones. In
the ischemia-hypoxia condition, the most prevalent changes in the brain metabolites were found in the
hippocampal regions of both young and aged rats; but the effects were more evident in the aged animals. The
ischemia-hyperoxia procedure caused less dedicated changes in the brain metabolites, which may reflect more
limited tissue damage.
Conclusions: We conclude that the hippocampus turns out to be particularly susceptible to hypoxia overlaid on
cerebral ischemia and that old age further increases this susceptibility.
Background
It is well established that mitochondrial dysfunction and
oxidative damage are essential in the slowly progressive
neuronal death that is characteristic of aging and neurode-
generative disorders, including Alzheimer and Parkinson’s
diseases [1-3]. The brain, which consumes large amounts
of oxygen, is particularly vulnerable to oxidative stress.
Antioxidant defense systems can be upregulated in
response to increased reactive oxygen species (ROS) [1].
Although these systems may confer protection against
ROS, they are not fully effective in preventing oxidative
damage. Moreover, efficiency of gene expression may
decline or become defective with progressive age, as oxida-
tive damage to the genome increases, which diminishes
the enzymatic antioxidant efficiency [4,5]. Oxidative stress
is considered the prevalent mechanism by which impaired
cerebral blood flow, hypoxia, and hyperoxia all cause neu-
ronal damage at the mitochondrial level due to increased
ROS production that overwhelms the antioxidant capacity
[6-8]. In addition, evidence accumulates that reduced cere-
bral blood flow plays a role in the pathogenesis of Alzhei-
mer’s disease [9] and contributes to cognitive decline
which is usually present during aging [10].
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present study was designed to test whether the ische-
mia-induced metabolic impairment would be affected by
varying oxygen supply due to hypoxia or hyperoxia in
the rat brain. We addressed this issue by measuring the
concentrations of selected metabolites, using proton
magnetic resonance spectroscopy (
1H-MRS), in two con-
trastingly different age-groups of animals: young - 3
months old and aged - 24 months old rats. Furthermore,
we sought to determine whether age, in itself, affects the
level of brain metabolites. In general, the study demon-
strates that hypoxia, overlaid on cerebral ischemia, was
a dedicatedly stronger detriment to the brain metabolite
content than was hyperoxia in both young and old ani-
mals. The hippocampus appeared particularly suscepti-
ble to hypoxia-ischemia perturbation and old age
further increased this susceptibility.
Methods
Animals and ischemic procedure
All procedures were performed in accordance with the
guidelines of EC Directive 86/609/EEC for animal
experiments and the study protocol was approved by a
local Ethics Committee.
A total of 60 adult female Wistar rats were used for the
main experiments. Additional 26 rats of either sex were
used for a preliminary phase of the study in which gender
differences in the survival rate during prolonged hypoxic
and hyperoxic exposures after antecedent ischemic brain
insult and the control brain content of metabolites with-
out ischemia were assessed, as outlined below. The 60
animals were divided into two contrasting age-groups:
young - 3 months old (the mean ± SD weight of 230 ± 20
g) and aged - 24 months old (280 ± 30 g), each consisting
of 30 rats. Either age-group was further subdivided into
three subgroups of 10 rats each. Two of these subgroups
were anesthetized with Nembutal (30 mg·kg
-1,i . p . ) ,a f t e r
overnight fast, and were subjected to the ischemic proce-
dure consisting of surgical ligation of the right carotid
artery. One each of these subgroups was then hypoxia or
hyperoxia-treated. The animals of the remaining third
subgroup in either age category were used for basal, con-
trol measurements of brain metabolites and, therefore,
were intact and untreated.
Gender differences - preliminary experiments
The choice of female rats for the main part of the study
was preceded by preliminary experiments in which the
possible gender-related differences in endurance to pro-
longed hypoxia and hyperoxia applied against the back-
ground of cerebral ischemia induced by unilateral
common carotid artery occlusion, as outlined below,
were investigated. In this phase of the study 16 addi-
tional rats were used; 8 of either sex. Six out of the 8
male rats died during ischemia-hypoxia, whereas no
mortality was noted among female rats. This result
prompted us to continue the study in female rats only,
even though the hyperoxia-ischemia procedure did not
cause any mortality in either male or female rats.
Moreover, in additional 10 female rats we investigated
the effects of hypoxia alone (12% inspired O2), without
the antecedent cerebral ischemia, on the content of the
brain metabolites measured (see the methodological
details below). We found that hypoxia, in itself, did not
significantly perturb the content of the metabolites.
Thus, the levels of metabolites found in the normoxic
rats were taken as basal control for those animals that
were subjected to ischemia-hypoxia and ischemia-hyper-
oxia procedures.
Induction of hypoxia and hyperoxia against the
background of ischemia
After the ischemic injury, the rats of the young and aged
subgroups, breathed unassisted in Plexiglas chambers for
24 h in hypoxia (12% inspired O2 in N2) or hyperoxia
(100% O2) at 23°C. The chambers were recirculated
with a pump; CO2 was continuously monitored by a
capnograph and its excess was removed from the cham-
ber air with Bara Lyme. Boric acid was mixed with the
litter to minimize the emission of urinary ammonia. The
remaining, control subgroups of rats, in either age-
group, were subjected to the same experimental proce-
dures, except the ischemic injury, and breathed normal
air instead of hypoxic or hyperoxic gas mixtures. At the
end of the exposure period, all rats were decapitated
and, in two minutes, three different parts of brain tissue,
fronto-parietal and occipital cortices and hippocampus
from both hemispheres were removed, weighed, frozen
in liquid nitrogen, and stored at -80°C.
Sample preparation
Perchloric acid (PCA) tissue extracts from the brain areas
outlined above were made as described elsewhere [11]
and analyzed separately. Briefly, each brain area was
homogenized at 5 ml/g in an ice-cold 0.1 M PCA-D2O
solution. The homogenates were centrifuged at 15000 × g
for 15 min at 0°C. The supernatant was kept, and the pel-
let was resuspended in the same original volume of buf-
fer, homogenized, and centrifuged once more, as outlined
above. The two supernatants were pooled and 600 μlo f
the final solution were used for
1H-MRS study. Extracts
were made from both hemispheres. Thus, a set of six
samples was prepared from each animal for the subse-
quent spectroscopic measurement.
Brain metabolites and data acquisition
We focused on the brain metabolites, detectable in the
proton spectra, which are identifiable at clinical
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response to ischemia-hypoxia, as found in our previous
study (12), and could likely respond also to ischemia-
hyperoxia treatment. The following metabolites were
quantified: alanine (Ala), choline-containing compounds
(Cho), total creatine (Cre), g-aminobutyric acid (GABA),
glutamate (Glu), glutamine (Gln), lactate (Lac), myo-ino-
sitol (mI) and N-acetylaspartate (NAA). Since Cre,
usually considered as an internal concentration refer-
ence in various pathological states, could not be used
for this purpose due to its potential variability in the
experimental model used, a solution of 3-(trimethylsi-
lyl)-2,2’,3,3’-tetradeuteropropionic acid (TMSP-d4)w a s
used as an external standard for the quantitative mea-
surements in the present investigation.
Proton magnetic resonance spectra were acquired with
an AVANCE NMR spectrometer (Bruker BioSpin,
Milan, Italy), using a pulse-acquired sequence at 300
MHz at 7.05 T and temperature of 300 K. Typical para-
meters used for data acquisition consisted of a sweep
width of 4 kHz, 16 K sample points, TR = 10 s, and 120
scans. Water suppression was achieved by applying a
Bruker-made pulse sequence. Extracts (600 μl) were
inserted in a 5 mm MRS tube. A coassial insert contain-
ing a solution of 30 mM TMSP-d4 in D2O was used as
an external standard in each spectroscopic investigation.
The quantification of metabolites in brain extracts was
preceded by a preliminary work performed on a set of
individual metabolite solutions and a mixture model
solution, containing the chemical species of interest (all
chemicals purchased from Sigma Chemical Company,
S t .L o u i s ,M O ) .T h em o d e ls o l u t i o nc o n t a i n e dk n o w n
amounts of NAA (100 mM), Ala (10 mM), Cre (100
mM), GABA (100 mM), Glu (100 mM), Lac (25 mM),
mI (100 mM), and phosphoric acid (50 mM) in 0.1 M
D2O. Pure compound solutions were prepared in the
same way. Special care was devoted to pH of solutions,
which was adjusted to 1.5, since it is critical for a quan-
titative MRS evaluation of brain extracts [12,13]. Atten-
tion was paid to keep the post-mortem changes of brain
tissue to a minimum, to avoid increases in tissue lactate
and GABA levels [14].
Data processing
Proton assignments were made by comparing reso-
nances of individual D2O solutions of the metabolites
under investigation at the same pH value of the extracts
[15]. All chemical shifts were referenced to the TMSP-
d4 signal at 0.0 ppm. The peak areas were determined
by the integration of the identified resonances and were
normalized to the TMSP-d4 signal area. Solutions of gly-
cine (Gly), ranging from 3.0 to 60 μmol, were prepared
and MRS-investigated to establish a calibration curve,
against which the concentrations of the measured
metabolites were evaluated. The volume of each Gly
solution was adjusted to a total volume of 600 μl. The
integral values of Gly were normalized to the 30 mM
TMSP-d4 solution contained in a coassial capillary
inserted into the MRS tube. The ratio of peak area of
each metabolite to signal area of TMSP-d4 was fitted to
the linear concentration curve of Gly. Finally, the abso-
lute quantity of a metabolite (in mmol/kg wet weight)
was corrected by normalizing the number of its protons
to the number of Gly protons (2H).
Statistical analysis
Two-way ANOVA was used to test the effects of age,
treatment (ischemia-hypoxia and ischemia-hyperoxia) or
age × treatment, for each metabolite in the three brain
regions studied and for both hemispheres. The differ-
ences contributed by the age factor following the two
different treatment conditions were further analyzed by
ap a r a m e t r i c( u n p a i r e dt-test) or nonparametric (Mann-
Whitney U test) method. The Bonferroni correction was
applied to account for multiple comparisons. P < 0.05
was considered significant in all statistical evaluations.
Results
Basal brain levels of metabolites in young and aged rats
In the control untreated age-groups, i.e., young and
aged normoxic rats, as opposed to the experimentally
treated groups outlined in the paragraphs below, statis-
tical analysis revealed no significant difference between
the two brain hemispheres; therefore, the concentration
of each metabolite was averaged from the pooled data
representing the symmetric brain areas in each rat.
There were neither intragroup nor intergroup statistical
differences in the basal concentrations of the corre-
sponding metabolites in the fronto-parietal and occipital
cortices. However, Ala and Lac were appreciably higher
in the hippocampus of the young rats compared with
the respective values in the cortices (P < 0.05). In addi-
tion, the Lac and mI levels were higher in the hippo-
campus of the aged rats compared with the respective
values in the young rats (P < 0.05) (see control columns
in Tables 1, 2, 3, 4, 5 and 6).
Effects of ischemia-hypoxia and ischemia-hyperoxia
in the fronto-parietal cortex
Ischemia-hypoxia significantly increased the amount of
Lac in the fronto-parietal cortex of both hemispheres in
both young and aged rats (P < 0.001), compared with
the respective control groups. In addition, the procedure
elicited a significant increase in mI on the left side (P <
0.05) and a decease in GABA on the right side, contral-
ateral and ipsilateral to the ischemic injury, respectively,
in both young (P < 0.001) and aged rats (P < 0.05)
(Tables 1, 2). There were no appreciable differences in
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between the young and old rats.
Ischemia-hyperoxia also increased the amount of Lac
in the fronto-parietal cortex in both young and aged
rats, with respect to their age-matched control values, in
both right and left hemispheres. In both age-groups,
these increases, albeit significant, were somewhat smal-
ler than those found in the corresponding brain areas
during ischemia-hypoxia, but the decline in Lac increase
in ischemia-hyperoxia was less pronounced in the aged
rats (Tables 1, 2). In the young rats, the levels of mI
tended to be enhanced on both sides, although this
effect, along with reductions in Ala and GABA, was sig-
nificant only on the right side, ipsilateral to the occlu-
sion (P < 0.05) (Table 1). In contrast, in the old rats the
increase in mI during ischemia-hyperoxia reached
Table 1 Effects of ischemia-hypoxia and ischemia-hyperoxia in the fronto-parietal cortex of young rats
Ischemia-hypoxia Ischemia-hyperoxia
Metabolite Control Right Left Right Left
Alanine 0.66 ± 0.05 0.60 ± 0.03 0.66 ± 0.09 0.39 ± 0.07* 0.60 ± 0.08
Choline 3.74 ± 0.22 3.47 ± 0.13 3.88 ± 0.15 3.73 ± 0.26 3.58 ± 0.16
Creatine 10.99 ± 0.50 11.90 ± 0.10 12.78 ± 0.75 11.44 ± 0.65 11.43 ± 0.44
GABA 2.16 ± 0.11 1.40 ± 0.08** 1.67 ± 0.34 1.53 ± 0.28* 1.88 ± 0.28
Glutamate 14.44 ± 0.45 13.88 ± 0.45* 15.96 ± 0.93 13.78 ± 0.80 13.98 ± 0.70
Lactate 11.88 ± 0.28 15.18 ± 0.29** 17.01 ± 1.00** 13.55 ± 1.10* 13.93 ± 0.23**
Myo-inositol 4.98 ± 0.62 6.47 ± 0.80 7.36 ± 0.40* 6.74 ± 0.26* 5.63 ± 0.24
N-acetylaspartate 10.29 ± 0.16 10.33 ± 0.40 12.08 ± 0.50** 10.41 ± 0.65 10.64 ± 0.60
Concentrations of metabolites (mmol/kg w/w) in young rats, under normoxic condition (control), ischemia-hypoxia, and ischemia-hyperoxia. Data are means ± SE
(n = 10 rats/group). Values, determined by proton MRS as outlined in the Methods, are given for the right (ipsilateral to cerebral ischemic injury) and left
(contralateral) hemisphere. *P < 0.05 and **P < 0.01 compared with controls.
Table 2 Effects of ischemia-hypoxia and ischemia-hyperoxia in the fronto-parietal cortex of aged rats
Ischemia-hypoxia Ischemia-hyperoxia
Metabolite Control Right Left Right Left
Alanine 0.63 ± 0.07 0.59 ± 0.04 0.58 ± 0.06 0.93 ± 0.34 0.66 ± 0.03
Choline 3.43 ± 0.09 3.74 ± 0.08 3.87 ± 0.23 3.58 ± 0.15 4.01 ± 0.09
Creatine 11.63 ± 0.24 11.67 ± 0.35 12.49 ± 0.39 10.80 ± 0.35 11.88 ± 0.21
GABA 1.79 ± 0.18 1.28 ± 0.08* 1.54 ± 0.31 1.13 ± 0.35* 2.18 ± 0.25
Glutamate 15.03 ± 0.26 15.09 ± 0.45 15.92 ± 0.80 12.52 ± 0.80** 15.28 ± 0.90
Lactate 12.59 ± 0.30 16.43 ± 0.40*** 16.45 ± 0.83*** 15.91 ± 1.00** 15.66 ± 0.76**
Myo-inositol 5.63 ± 0.46 6.64 ± 0.25 7.02 ± 0.50* 6.11 ± 0.50 6.67 ± 0.33*
N-acetylaspartate 10.69 ± 0.21 11.53 ± 0.37 11.66 ± 0.37 9.65 ± 0.32 11.09 ± 0.36
Concentrations of metabolites (mmol/kg w/w) in aged rats, under normoxic condition (control), ischemia-hypoxia, and ischemia-hyperoxia. Data are means ± SE
(n = 10 rats/group). Values, determined by proton MRS as outlined in the Methods, are given for the right (ipsilateral to cerebral ischemic injury) and left
(contralateral) hemisphere. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with controls.
Table 3 Effects of ischemia-hypoxia and ischemia-hyperoxia in the occipital cortex of young rats
Ischemia-hypoxia Ischemia-hyperoxia
Metabolite Control Right Left Right Left
Alanine 0.64 ± 0.04 0.76 ± 0.08 0.73 ± 0.19 0.73 ± 0.02 0.50 ± 0.04
Choline 3.75 ± 0.05 3.59 ± 0.06 3.88 ± 0.23 4.34 ± 0.25 4.32 ± 0.29
Creatine 10.64 ± 0.10 11.81 ± 0.25** 12.08 ± 0.61 12.97 ± 0.60* 13.21 ± 1.00*
GABA 1.72 ± 0.21 1.76 ± 0.20 2.06 ± 0.54 2.52 ± 0.50* 2.02 ± 0.28
Glutamate 14.55 ± 0.18 14.91 ± 0.29 15.58 ± 1.50 16.17 ± 0.80* 16.02 ± 0.60*
Lactate 12.10 ± 0.51 16.56 ± 0.49*** 17.87 ± 0.33*** 16.03 ± 1.20** 15.73 ± 0.85**
Myo-inositol 5.67 ± 0.08 8.56 ± 0.40* 8.18 ± 1.14* 8.42 ± 0.90** 8.22 ± 0.80**
N-acetylaspartate 10.15 ± 0.21 11.01 ± 0.62 11.47 ± 0.85 11.85 ± 0.41 11.53 ± 0.44
Concentrations of metabolites (mmol/kg w/w) in young rats, under normoxic condition (control), ischemia-hypoxia, and ischemia-hyperoxia. Data are means ± SE
(n = 10 rats/group). Values, determined by proton MRS as outlined in the Methods, are given for the right (ipsilateral to cerebral ischemic injury) and left
(contralateral) hemisphere. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with controls.
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ietal cortex, which was accompanied by decreases in
Glu and GABA on the ipsilateral side (Table 2).
Effects of ischemia-hypoxia and ischemia-hyperoxia in the
occipital cortex
Both ischemia-hypoxia and ischemia-hyperoxia induced
a significant increase in Lac levels in the occipital cortex
in both brain hemispheres of the young and aged rats,
compared with the baseline levels (Tables 3, 4). In the
young rats, both gas conditions also increased the level
of mI (P < 0.05). In these rats ischemia-hyperoxia, but
not ischemia-hypoxia, increased the level of Cre and
Glu. All these increases were of similar magnitude in
both hemispheres. The hyperoxic increase in mI was
absent in the aged rats. Ischemia-hyperoxia also
Table 4 Effects of ischemia-hypoxia and ischemia-hyperoxia in the occipital cortex of aged rats
Ischemia-hypoxia Ischemia-hyperoxia
Metabolite Control Right Left Right Left
Alanine 0.61 ± 0.06 0.72 ± 0.03 0.85 ± 0.21 0.88 ± 0.07* 0.57 ± 0.12
Choline 3.50 ± 0.14 3.61 ± 0.07 3.74 ± 0.23 3.94 ± 0.36 3.72 ± 0.07
Creatine 10.53 ± 0.37 10.86 ± 0.24 10.76 ± 0.31 11.31 ± 0.90 11.32 ± 0.46
GABA 1.86 ± 0.24 2.02 ± 0.13 2.11 ± 0.59 3.16 ± 0.60* 2.25 ± 0.33
Glutamate 13.89 ± 0.51 13.73 ± 0.21 13.93 ± 0.46 13.71 ± 1.30 14.06 ± 0.26
Lactate 12.82 ± 0.49 16.12 ± 0.44*** 16.37 ± 0.53*** 15.53 ± 0.48** 15.69 ± 0.60**
Myo-inositol 6.55 ± 0.18 7.06 ± 0.35 7.76 ± 0.85* 7.63 ± 0.75 7.12 ± 0.33
N-acetylaspartate 9.98 ± 0.36 10.48 ± 0.30 10.87 ± 0.34 10.36 ± 0.60 10.14 ± 0.38
Concentrations of metabolites (mmol/kg w/w) in aged rats, under normoxic condition (control), ischemia-hypoxia, and ischemia-hyperoxia. Data are means ± SE
(n = 10 rats/group). Values, determined by proton MRS as outlined in the Methods, are given for the right (ipsilateral to cerebral ischemic injury) and left
(contralateral) hemisphere. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with controls.
Table 5 Effects of ischemia-hypoxia and ischemia-hyperoxia in the hippocampus of young rats
Ischemia-hypoxia Ischemia-hyperoxia
Metabolite Control Right Left Right Left
Alanine 0.89 ± 0.08 0.43 ± 0.02* 0.37 ± 0.05* 0.70 ± 0.20 0.85 ± 0.03
Choline 4.11 ± 0.12 2.20 ± 0.45** 2.48 ± 0.11** 3.48 ± 0.45 3.77 ± 0.17
Creatine 11.96 ± 0.20 8.95 ± 0.48* 8.28 ± 0.62** 10.50 ± 1.50 11.08 ± 0.23
GABA 2.12 ± 0.12 0.73 ± 0.16** 0.88 ± 0.24** 2.07 ± 0.35 1.82 ± 0.09
Glutamate 14.93 ± 0.71 9.27 ± 1.50* 8.77 ± 0.81** 12.36 ± 1.50 11.33 ± 0.70**
Lactate 14.63 ± 0.22 12.45 ± 1.50* 12.23 ± 0.80* 16.57 ± 0.45** 15.44 ± 0.15*
Myo-inositol 7.47 ± 0.35 5.26 ± 1.10 5.92 ± 0.20* 7.90 ± 0.80 8.22 ± 0.38
N-acetylaspartate 9.70 ± 0.12 6.88 ± 1.40* 6.81 ± 0.24* 8.67 ± 1.20 8.79 ± 0.32
Concentrations of metabolites (mmol/kg w/w) in young rats, under normoxic condition (control), ischemia-hypoxia, and ischemia-hyperoxia. Data are means ± SE
(n = 10 rats/group). Values, determined by proton MRS as outlined in the Methods, are given for the right (ipsilateral to cerebral ischemic injury) and left
(contralateral) hemisphere. *P < 0.05 and **P < 0.01 compared with controls.
Table 6 Effects of ischemia-hypoxia and ischemia-hyperoxia in the hippocampus of aged rats
Ischemia-hypoxia Ischemia-hyperoxia
Metabolite Control Right Left Right Left
Alanine 0.91 ± 0.12 0.37 ± 0.05* 0.38 ± 0.07* 1.28 ± 0.36 1.01 ± 0.23
Choline 4.27 ± 0.08 2.56 ± 0.40*** 2.69 ± 0.18*** 4.03 ± 0.28 4.03 ± 0.26
Creatine 12.69 ± 0.32 7.52 ± 0.90* 7.80 ± 0.75** 12.31 ± 0.41 11.68 ± 0.58
GABA 2.65 ± 0.24 1.38 ± 0.39** 1.66 ± 0.23** 3.22 ± 0.48 2.69 ± 0.31
Glutamate 15.53 ± 0.44 6.97 ± 0.96*** 6.88 ± 0.48*** 12.67 ± 1.40* 13.06 ± 1.00**
Lactate 16.24 ± 0.34 12.69 ± 1.42*** 11.38 ± 0.55*** 17.05 ± 0.26* 17.03 ± 1.00*
Myo-inositol 8.26 ± 0.45 5.27 ± 1.15* 5.87 ± 0.66** 8.75 ± 0.50 9.01 ± 0.56
N-acetylaspartate 10.51 ± 0.18 6.35 ± 0.45*** 6.00 ± 0.42*** 9.41 ± 0.37 9.13 ± 0.46
Concentrations of metabolites (mmol/kg w/w) in aged rats, under normoxic condition (control), ischemia-hypoxia, and ischemia-hyperoxia. Data are means ± SE
(n = 10 rats/group). Values, determined by proton MRS as outlined in the Methods, are given for the right (ipsilateral to cerebral ischemic injury) and left
(contralateral) hemisphere. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with controls.
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that of Ala in the aged group only on the side ipsilateral
to occlusion (P < 0.05). The other metabolites remained
unchanged in both age-groups (Tables 3, 4).
Effects of ischemia-hypoxia and ischemia-hyperoxia in the
hippocampus
Ischemia-hypoxia had a marked reducing effect on all
the metabolites under investigation in the hippocampus
in both hemispheres and both age-groups, compared
with the respective age-matched control values. In con-
trast, ischemia-hyperoxia only caused decreases in the
level of Glu and increases in Lac in both age-groups,
with inappreciable changes in the other metabolites
(Tables 5, 6). These alterations appeared grossly similar
in both age-groups.
Discussion
In the present study, measurements of a series of cere-
bral metabolites were performed by
1H-MRS to establish
the tissue alterations following hypoxic or hyperoxic
exposure performed on the background of ischemic
insult. The major finding of the study is that cerebral
ischemia associated with hypoxia caused derangement of
the energy-related content of brain metabolites which
was conspicuously more pronounced in the hippocam-
pal than cortical areas. In the hippocampus, ischemia
associated with hypoxia reduced the content of all brain
metabolites studied, and the effects were more evident
in the aged animals. Alterations in brain metabolites
were unrelated to the ischemia-injured hemisphere, as
they were about equally distributed in the respective
areas of both hemispheres. The ischemia-hyperoxia pro-
cedure caused much less dedicated changes in the brain
metabolites, which may reflect more limited tissue
damage.
It is known that oxidative stress is a relevant mechan-
ism involved in the process of brain aging [4,5]. More-
over, aging is the most important risk factor for
neurodegenerative disorders, such as Alzheimer and
Parkinson’s disease [16,17]. Oxidative damage is essen-
tial for most neurodegenerative diseases [2,3,16,18].
Excessive production of ROS also is germane to the
neuronal damage associated with ischemia and brain
edema, ranging from metabolic alterations to apoptosis
or necrosis [8,19]. Hypoxia and hyperoxia, the former
being often a sequel of a disease process and the latter a
treatment modality, act as inducers of ROS formation
[6-8]. In the present study, therefore, we set out to
investigate the age-differences in the content of brain
metabolites in response to varying oxygen supply on the
background of ischemic insult. To this end we devel-
oped a model of cerebral ischemia associated with expo-
sure to chronic hypoxia and hyperoxia in two
contrasting age-groups of rats, young and senescent, in
which selected metabolites were quantified by means of
proton magnetic resonance spectroscopy.
The ultimate goal of the present study was the identi-
fication of biochemical markers of oxidative stress in the
brain. That goal was not really achieved, as alterations
in metabolites were overall modest and variably differ-
ent. However, some basic pattern of metabolic brain
alterations was brought out. The results demonstrate no
significant age-dependent regional differences in the
brain content of metabolites, between young and aged
rats in the normoxic condition, except for the higher
levels of Lac and mI in the hippocampus of the aged
rats. These findings are consistent with the data
reported in other ex vivo studies [12,13]. Nevertheless,
the increase in Lac is an interesting finding in that the
L a cl e v e li nt h eh i p p o c a m p u sm i g h tb ec o n s i d e r e da
useful marker of aging. Indeed, increased Lac levels have
been found in the brains of healthy elderly people, as
measured by
1H-MRS [20]. Also, high levels of Lac have
been found in the brains of humans affected by pre-
senile dementia [21] or Alzheimer’s disease [22].
The present finding of reduced Lac concentration in
the hippocampus of ischemia-hypoxia-treated animals,
particularly evident in the aged animals, is in agreement
with our previously reported data [12]. The finding is,
however, at variance with the data reported by Higuchi
et al [23] who found increased Lac concentrations fol-
lowing global ischemia. However, one important point
to consider is the duration of the ischemia-hypoxic pro-
cedure, which in our study lasted for 24 h. It is probable
that during this longer period lactic acid, locally pro-
duced by neurons, was cleared by the circulatory system
and that the neuronal death due to combination of
hypoxia with ischemia ultimately resulted in a reduction
of Lac formation. On the other hand, increased hippo-
campal Lac concentration following ischemia-hyperoxia
may reflect a milder insult resulting only in neuronal
damage rather than death induced by hypoxia.
That hippocampus is a brain region particularly sus-
ceptible to metabolic derangement is confirmed by a
marked decrease in NAA concentration following the
ischemia-hypoxia insult. Reductions in NAA levels have
been found after neuronal damage or dysfunction, even
in the absence of neuronal death [24]. Moreover, an
age-related decrease in NAA has been found in human
cortical gray matter [25,26]. It is conceivable that ische-
mia-hyperoxia is a milder disturbance than ischemia-
hypoxia, inasmuch as the former did not cause any
changes in the hippocampal NAA concentration, at least
as revealed by the
1H-MRS resolution, which is a well
known index of neural viability. In the hippocampus,
only modest reductions of Glu levels were found after
ischemia-hyperoxia, whereas its substantial decreases
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findings are consistent with the hypothesis that ische-
mia-hypoxia causes a marked release of endogenous
Glu, thereby reducing its tissue content measured by
1H-MRS. However, it is impossible to establish to what
extent the reduced Glu concentration induced by ische-
mia-hypoxia might be an index of neuronal damage. In
addition, all other metabolites measured (i.e., GABA,
mI, choline, and Cre) were found to be significantly
reduced in the hippocampus of both young and aged
rats after the ischemia-hypoxia procedure, whereas
ischemia associated with hyperoxia did not cause any
significant changes in the content of these metabolites.
Unlike the hippocampal area that, according to our
findings, was much more susceptible to the effects of
hypoxic than hyperoxic treatment after antecedent cere-
bral ischemia, the fronto-parietal and occipital cortices
were similarly sensitive to both treatments. However,
metabolic alterations in both cortical areas were modest,
compared with those in the hippocampus. Lac concen-
trations increased in both cortical areas by both treat-
ments, but the effects of hypoxia were stronger than
those of hyperoxia, in both young and aged rats. This
difference probably reflects the prevalence of anaerobic
metabolism when ischemia is associated with hypoxia,
whereas hyperoxia may compensate, in part, for the
deleterious effects of ischemia. The increase in Lac in
cortical areas reflects neuronal damage, since unchanged
or slightly modified levels of NAA and Glu rather rule
out the occurrence of neuronal death. A similar trend
was followed by GABA, whose levels were reduced in
the fronto-parietal cortex. Depletion of Glu and GABA
tissue concentrations induced by hypoxia in the fronto-
parietal cortex are probably consequent to their release
elicited by the ischemic insult [27,28]. In contrast,
GABA concentration was significantly increased in the
occipital cortex of both young and aged rats after ische-
mia-hyperoxia.
There is a spate of pathological conditions in which
cerebral ischemia may ensue; most notably strokes or
thromboembolic brain events, transient ischemic attacks,
or neurodegenerative disorders. Both hypoxia and
hyperoxia are frequent accompaniments of cerebral
ischemia in clinical settings. Therefore, the study of the
effects on brain metabolites of a combination of either
gas condition with ischemia seemed warranted. Hypoxia
may be antecedent to brain event, such as in chronic
hypoxic lung pathologies, exemplified by obstructive
pulmonary disease or sleep-related breathing disorders
which, in fact, sharply increase the risk for brain
ischemic events [29], or may develop as a sequel of
breathing disorders secondary to brain ischemia. Either
way, hypoxia appears a major detriment to brain energy
metabolites as shown in the present study. Hyperoxia,
on the other hand, is often used as a pharmacological
tool to alleviate ischemic symptoms.
There are a number of limitations to this study. Histo-
logical and functional correlates of the cerebral ischemia
induced were not traced, nor was the brain tissue redox
status assessed. The study also was thought out as basi-
cally non-invasive during the 24-h period of the delivery
of inspired gas mixtures; therefore, no arterial blood gas
content and acid-base status were controlled. Further-
more, spectroscopic measurements were carried out in
brain tissue ex vivo and the extrapolation of the results to
in vivo conditions is not fully applicable. The resolution
of these issues would require alternative study designs.
Conclusions
Despite the limitations and although the exact determi-
nants of metabolic alterations in the brain are unsettled,
w eb e l i e v ew eh a v es h o w nt h a tt h ea s s o c i a t i o no f
hypoxia and cerebral ischemia impairs brain metabolism
and may be a particular detriment for the hippocampus-
controlled functions; for instance, memory and emotions
[30]. As hyperoxia associated with ischemia appears to
have no major brain tissue damaging effects, the study
does not disapprove a judicial use of O2-enriched
inspiratory gas mixtures to alleviate symptoms accompa-
nying cerebral ischemia. A better understanding of the
mechanisms underlying metabolic brain changes asso-
ciated with hypoxia and hyperoxia during ischemic
insults is essential to facilitate recognition of the opti-
mum health-related strategies for ischemia.
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